Published on 8 Apr 2024 on Zacks via Yahoo Finance
Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this drugmaker have returned -2.1%, compared to the Zacks S&P 500 composite's +2.6% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which Pfizer falls in, has lost 0.4%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.